The implications of serum enzymes and coagulation activities in postinfarction myocardial rupture

Shi-Min Yuan1, Hua Jing, Jacob Lavee

  • 1Department of Cardiothoracic Surgery, Affiliated Hospital of Taishan Medical College, Taian 27100, Shandong Province, People's Republic of China. shi_min_yuan@yahoo.com

Insights

Postinfarction myocardial rupture significantly elevates serum enzymes and coagulation markers, except fibrinogen. These biomarker profiles aid in diagnosing, treating, and predicting outcomes in rupture patients.

Area of Science:

  • Cardiology
  • Biochemistry
  • Medical Diagnostics

Background:

  • Cardiovascular diseases and serum enzyme/coagulation activity associations are known in myocardial infarction.
  • Alterations in these biomarkers specifically in postinfarction myocardial rupture are underreported.

Purpose of the Study:

  • To investigate and present the profiles of serum enzymes and coagulation activities in patients experiencing postinfarction myocardial rupture.

Main Methods:

  • Study included 19 patients undergoing surgical repair for postinfarction myocardial rupture (2004-2008).
  • Classified rupture types: free wall, papillary muscle, ventricular septal, and double structure.
  • Analyzed laboratory findings including serum enzymes and coagulation activities.

Main Results:

  • Coagulation markers and serum enzymes (except fibrinogen) significantly increased post-rupture.
  • Significant differences in D-dimer, PTT, LDH, CK, and CK-MB between survivors and non-survivors.
  • Elevated Troponin I levels observed early after rupture onset or surgical repair.

Conclusions:

  • Myocardial rupture causes marked elevations in serum enzymes and coagulation activities, excluding fibrinogen.
  • Biomarker evaluation can assist in diagnostic and treatment decisions.
  • These markers may help in assessing the clinical prognosis of myocardial rupture patients.
Abstract

Related Concept Videos

Blood Studies for Cardiovascular System I: Cardiac Biomarkers01:20

Blood Studies for Cardiovascular System I: Cardiac Biomarkers

Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
Myocarditis I: Introduction01:21

Myocarditis I: Introduction

Myocarditis is inflammation of the myocardium, which is the muscular layer of the heart.EtiologyMyocarditis has a diverse etiology, including a wide range of infectious and non-infectious causes:Infectious CausesViral: Common viruses include Coxsackie A and B, adenovirus, parvovirus B19, enteroviruses, and influenza A.Bacterial: Examples include infections caused by Streptococcus, Staphylococcus, and Mycoplasma species.Rickettsial: Infections like Rocky Mountain spotted fever can result in...
Acute Coronary Syndrome I: Introduction01:30

Acute Coronary Syndrome I: Introduction

Acute Coronary Syndrome (ACS) encompasses a spectrum of heart conditions caused by sudden obstruction of coronary arteries, typically resulting from the rupture of an atherosclerotic plaque and subsequent thrombus (blood clot) formation. This obstruction can lead to partial or complete blockage of blood flow, causing varying degrees of myocardial ischemia or infarction.ACS includes the following clinical entities:Unstable Angina (UA)Non-ST-Elevation Myocardial Infarction (NSTEMI)ST-Elevation...
Coagulation01:09

Coagulation

The coagulation phase is a critical part of the body's process to prevent blood loss following injury to blood vessels. It involves chemical reactions that form a clot to seal the injured area. The clotting process begins shortly after injury, within 15-20 seconds for severe damage and 1-2 minutes for minor injuries.
During the coagulation phase, clotting factors, or procoagulants, play a vital role in initiating and progressing the coagulation cascade. This cascade is a series of reactions...
Anticoagulant Drugs: Low-Molecular-Weight Heparins01:30

Anticoagulant Drugs: Low-Molecular-Weight Heparins

Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...